Literature DB >> 11105086

[Multiple sclerosis, spinal cord ependymoma and intracranial meningioma: case report].

M F Costa1, S A Novis, P Niemeyer Filho, M L Pimentel, R F Novis, F Duarte.   

Abstract

We report the association a multiple sclerosis (MS), spinal cord tumour and intracranial tumor in a 63 years-old female patient with a 10 years history of relapsing/remitting MS. Symptoms usually remitted in response to costicosteroid therapy. In 1997 the patient presented with paraparesis and paresis of right arm which did not respond to corticotherapy. A spinal RMI revealed in the cervical spinal an intra spinal cord tumour, further diagnosed as ependymoma, and a parietal region meningioma. We call attention to this rare association of central nervous system tumour and MS, enphasizing the need for investigation of new and uncommon symptoms during the evolution of MS.

Entities:  

Mesh:

Year:  2000        PMID: 11105086     DOI: 10.1590/s0004-282x2000000600025

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  4 in total

1.  Genetic characterization of gliomas arising in patients with multiple sclerosis.

Authors:  Adam Khalil; Hilary Serracino; Denise M Damek; Douglas Ney; Kevin O Lillehei; B K Kleinschmidt-DeMasters
Journal:  J Neurooncol       Date:  2012-05-01       Impact factor: 4.130

2.  Meningioma growth and interferon beta-1b treated multiple sclerosis: coincidence or relationship?

Authors:  A Drevelegas; E Xinou; D Karacostas; D Parissis; G Karkavelas; I Milonas
Journal:  Neuroradiology       Date:  2005-06-25       Impact factor: 2.804

Review 3.  The sad plight of multiple sclerosis research (low on fact, high on fiction): critical data to support it being a neurocristopathy.

Authors:  Peter O Behan; Abhijit Chaudhuri
Journal:  Inflammopharmacology       Date:  2010-09-24       Impact factor: 5.093

4.  Brain radiation and possible presentation of multiple sclerosis.

Authors:  Vahid Shaygannejad; Mohammad Zare; Helia Maghzi; Parisa Emami
Journal:  J Res Med Sci       Date:  2013-03       Impact factor: 1.852

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.